Evaluation of a docetaxel-cisplatin-fluorouracil-Au complex in human oral carcinoma cell line

References

• Paul BF, Kenneth DT. Advances in cancer research. Cambridge (MA): Academic Press; 2021.
   Google Scholar
• Fatemeh A, Nafiseh V, Parya E, et al. Drug resistance against 5-fluorouracil and cisplatin in the treatment of head and neck squamous cell carcinoma: a systematic review. J Dent Res Clin Dent Prospects. 2021;15(3):219–225.
   PubMedGoogle Scholar
• Andreas EA, Regina G, Xu Q, et al. Efficacy and toxicity of docetaxel combination chemotherapy for advanced squamous cell cancer of the head and neck. Mol Clin Oncol. 2017;7(1):151–157.
   PubMedGoogle Scholar
• da Rocha MCO, da Silva PB, Radicchi MA, et al. Docetaxel-loaded solid lipid nanoparticles prevent tumor growth and lung metastasis of 4T1 murine mammary carcinoma cells. J Nanobiotechnol. 2020;18(1):43.
   PubMed Web of Science ®Google Scholar
• Sindhu VG, Safeena K, Ramanan SP, et al. Establishment and characterization of triple drug resistant head and neck squamous cell carcinoma cell lines. Molecular Med Reports. 2015;12(2):3025–3032.
   PubMed Web of Science ®Google Scholar
• Tae MY, Sun-Ae K, Dong HL, et al. Livin enhances chemoresistance in head and neck squamous cell carcinoma. Oncol Reports. 2017;37(6):3667–3673.
   PubMed Web of Science ®Google Scholar
• Haddad RI, Posner M, Hitt R, et al. Induction chemotherapy in locally advanced squamous cell carcinoma of the head and neck: role, controversy, and future directions. Ann Oncol. 2018;29(5):1130–1140.
   PubMed Web of Science ®Google Scholar
• Devale T, Vini S, Rajesh K, et al. Randomized controlled study comparing efficacy and toxicity of weekly vs. 3-weekly induction chemotherapy in locally advanced head and neck squamous cell carcinoma. Front Oncol. 2020;10:1284.
   PubMed Web of Science ®Google Scholar
• Maureen B, Michel L, Anne-Françoise D, et al. Predictive factors of toxicity of TPF induction chemotherapy for locally advanced head and neck cancers. BMC Cancer. 2021;21:360.
   PubMed Web of Science ®Google Scholar
• Jan BV. Where and when to use induction chemotherapy in head and neck squamous cell cancer. In: Vermorken JB, Budach V, Leemans CR, Machiels JP, Nicolai P, O’Sullivan B, editors. Critical issues in head and neck oncology. Cham: Springer; 2021. p. 155–179.
   Google Scholar
• Katsunori K, Kiyoto S, Hisanori A. Preliminary study of chemoradiotherapy using modified docetaxel, cis-diaminodichloroplatinum, and 5-fluorouracil for sinonasal squamous cell carcinoma. OTO Open. 2021;5(3):2473974X211045298.
   PubMedGoogle Scholar
• Nahid R, Anjana P. Engineered nanoparticles as drug delivery systems. Boca Raton (FL): CRC Press; 2022.
   Google Scholar
• Yashwant VP, Jayvadan KP. Pharmacokinetics and pharmacodynamics of nanoparticulate drug delivery systems. New York: Springer Nature; 2022.
   Google Scholar
• Wang Z, Dong J, Zhao Q, et al. Gold nanoparticle-mediated delivery of paclitaxel and nucleic acids for cancer therapy (review). Mol Med Rep. 2020;22:4475–4484.
   PubMed Web of Science ®Google Scholar
• Shrestha B, Wang L, Zhang H, et al. Gold nanoparticles mediated drug-gene combinational therapy for breast cancer treatment. Int J Nanomed. 2020;15:8109–8119.
   PubMed Web of Science ®Google Scholar
• Vodyashkin AA, Rizk MGH, Kezimana P, et al. Application of gold nanoparticle-based materials in cancer therapy and diagnostics. Chem Eng. 2021;5(4):69.
   Google Scholar
• Tomşa AM, Răchişan AL, Aldea AA, et al. Perspectives of gold nanoparticles and their applications in pancreatic cancer (review). Exp Ther Med. 2021;21:258.
   PubMed Web of Science ®Google Scholar
• Faid AH, Shouman SA, Badr YA, et al. Enhanced cytotoxic effect of doxorubicin conjugated gold nanoparticles on breast cancer model. BMC Chem. 2022;16:90.
   PubMed Web of Science ®Google Scholar
• Shahidi M, Abazari O, Dayati P, et al. Aptamer-functionalized chitosan-coated gold nanoparticle complex as a suitable targeted drug carrier for improved breast cancer treatment. Nanotechnol Rev. 2022;11(1):2875–2890.
   Web of Science ®Google Scholar
• Yang Z, Wang D, Zhang C, et al. The applications of gold nanoparticles in the diagnosis and treatment of gastrointestinal cancer. Front Oncol. 2022;11:819329.
   PubMed Web of Science ®Google Scholar
• Alle M, Sharma G, Lee SH, et al. Next-generation engineered nanogold for multimodal cancer therapy and imaging: a clinical perspectives. J Nanobiotechnol. 2022;20:222.
   PubMed Web of Science ®Google Scholar
• Archana SP, Riya H, Anand PG, et al. Exploring the solvent-anti-solvent method of nanosuspension for enhanced oral bioavailability of lovastatin. Turk J Pharm Sci. 2021;18(5):541–549.
   PubMed Web of Science ®Google Scholar
• Fariba P, Elaheh R, Sima AA, et al. Solubilization methods for paclitaxel and docetaxel: an overview. Pharm Sci. 2022;28(2):208–223.
   Google Scholar
• Locharoenrat K. Efficacy of nanodiamond–doxorubicin complexes on human breast adenocarcinoma cell lines. Artif Cells Nomed Biotechnol. 2019;47(1):4053–4058.
   PubMed Web of Science ®Google Scholar
• Sanità G, Carrese B, Lamberti A. Nanoparticle surface functionalization: how to improve biocompatibility and cellular internalization. Front Mol Biosci. 2020;7:587012.
   PubMed Web of Science ®Google Scholar
• Lai YH, Chih-Sheng C, Chin-Hao H, et al. Development and characterization of a fucoidan-based drug delivery system by using hydrophilic anticancer polysaccharides to simultaneously deliver hydrophobic anticancer drugs. Biomolecules. 2020;10(7):970.
   PubMed Web of Science ®Google Scholar
• Teruo H, David RB, Tsuyoshi M, et al. Blue moon ensemble simulation of aquation free energy profiles applied to Mono and bifunctional platinum anticancer drugs. J Comput Chem. 2020;41(22):1973–1984.
   PubMed Web of Science ®Google Scholar
• González-López MA, Gutiérrez-Cárdenas EM, Sánchez-Cruz C, et al. Reducing the effective dose of cisplatin using gold nanoparticles as carriers. Cancer Nanotechnol. 2020;11:4.
   Web of Science ®Google Scholar
• Farhat J, Aisha L, Fiza A, et al. Synthesis of 5-fluorouracil cocrystals with novel organic acids as coformers and anticancer evaluation against HCT-116 colorectal cell lines. Cryst Growth Des. 2020;20(4):2406–2414.
   Web of Science ®Google Scholar
• Indiani CDV, Bethina TS, Mauricio LF, et al. Reducing the effective dose of cisplatin using gold nanoparticles as carriers. J Nanoparticle Res. 2020;22:133.
   Google Scholar
• Zembruski NC, Stache V, Haefeli WE, et al. 7-Aminoactinomycin D for apoptosis staining in flow cytometry. Anal Biochem. 2012;429(1):79–81.
   PubMed Web of Science ®Google Scholar
• Panuszko A, Bruździak P, Śmiechowski M, et al. DMSO hydration redefined: unraveling the hydrophobic hydration of solutes with a mixed hydrophilic–hydrophobic characteristic. J Molecular Liquids. 2019;294:111661.
   Web of Science ®Google Scholar
• Imamura Y, Tanaka K, Kiyota N, et al. Docetaxel plus cisplatin in recurrent and/or metastatic non-squamous-cell head and neck cancer: a multicenter phase II trial. Med Oncol. 2021;38(11):128.
   PubMed Web of Science ®Google Scholar
• Aarti M, Shridhar N, Swaminathan S, et al. Novel resveratrol and 5-fluorouracil coencapsulated in PEGylated nanoliposomes improve chemotherapeutic efficacy of combination against head and neck squamous cell carcinoma. Biomed Res Inter. 2014;2014:424239.
   PubMed Web of Science ®Google Scholar
• Yuchen B, Qinfang , Yongyong L, Songwen Z, et al. Engineering docetaxel-loaded micelles for non-small cell lung cancer: a comparative study of microfluidic and bulk nanoparticle preparation. RSC Adv. 2018;8:31950–31966.
   PubMed Web of Science ®Google Scholar
• Roghayyeh VG, Seyed MR, Reza FM, et al. Optimization of docetaxel loading conditions in liposomes: proposing potential products for metastatic breast carcinoma chemotherapy. Sci Reports. 2020;10:5569.
   PubMed Web of Science ®Google Scholar
• Huan Y, Qi Y, Yuan L, et al. Co-encapsulation of paclitaxel and 5-fluorouracil in folic acid-modified, lipid-encapsulated hollow mesoporous silica nanoparticles for synergistic breast cancer treatment. RSC Adv. 2022;12(50):32534–32551.
   PubMed Web of Science ®Google Scholar
• Ahmed K, Alexandra BT, Idan S, et al. Biodegradable controlled-release device for localized chemotherapeutic treatment of bladder cancer. ACS Biometer Sci Eng. 2021;7(6):2548–2557.
   PubMed Web of Science ®Google Scholar
• National Center for Biotechnology Information. National Library of Medicine. KB cells. [cited 2023 Feb 21]. https://www.ncbi.nlm.nih.gov/mesh/?term=KB+Cells.
   Google Scholar